scholarly journals beta 2-Microglobulin levels in serum and urine of rheumatoid arthritis patients on gold therapy.

1981 ◽  
Vol 40 (2) ◽  
pp. 157-160 ◽  
Author(s):  
D Latt ◽  
J B Weiss ◽  
M I Jayson
1980 ◽  
Vol 39 (4) ◽  
pp. 333-339 ◽  
Author(s):  
K G Sjoblom ◽  
T Saxne ◽  
F A Wollheim

1989 ◽  
Vol 35 (5) ◽  
pp. 766-772 ◽  
Author(s):  
D D DeMars ◽  
J A Katzmann ◽  
T K Kimlinger ◽  
J D Calore ◽  
R P Tracy

Abstract alpha 1-Microglobulin (alpha 1m), a glycoprotein (Mr = 30,000) found in serum and urine, is also present in serum conjugated to monomeric IgA (alpha 1-m-IgA). We have developed a simultaneous enzyme-linked immunoenzyme/immunoradiometric assay that involves three different monoclonal antibodies. Assay of serial dilutions of serum and urine demonstrated parallelism. Normal mean concentrations in serum (n = 75) were: total alpha 1m, 2.33 mumol/L; alpha 1m-IgA, 1.24 mumol/L; unconjugated (free) alpha 1m, 1.09 mumol/L; molar ratio (alpha 1m-IgA/total alpha 1m), 0.53. The mean concentration of alpha 1m in eight urine specimens from normal individuals was 0.19 mumol/L, with no detectable alpha 1m-IgA. A low urinary pH does not significantly affect assay results, unlike assays of beta 2-microglobulin. In patients with myeloma-related renal disease, total and free alpha 1m values for serum correlated well with values for creatinine and beta 2-microglobulin in serum.


Respiration ◽  
1996 ◽  
Vol 63 (5) ◽  
pp. 272-276 ◽  
Author(s):  
Terhi Söderblom ◽  
Peter Nyberg ◽  
Tom Pettersson ◽  
Matti Klockars ◽  
Henrik Riska

2015 ◽  
Vol 3 (1) ◽  
pp. 13-19
Author(s):  
A. Trailin ◽  
M. Pleten ◽  
A. Nikonenko ◽  
T. Ostapenko ◽  
N. Yefimenko

The most investigations of the biomarkers of renal allograft dysfunction (RAD) are limited by early post-operational period and are aimed at diagnosis of acute rejection of renal transplant. This work has aimed to establish additional characteristics of chronic RAD by using non-invasive biomarkers of the blood serum and urine.Materials and methods. 79 patients aged 16 to 59 years (47 men and 32 women) took part in our retrospective study. The alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamil transferase (GGT), alkaline phosphatase (ALP), N-acetyl-β-D-glucosaminidase (NAG); interleukins (IL-2, IL-8, IL-10) and beta-2-microglobulin were evaluated.Results. Increased IL-10 and β2-MG serum concentration, and increased urinary concentration and activity of β2-MG, IL-2, IL-8, NAG, AP, AST, GGT were typical for chronic RAD. Only NAG was independently significantly associated with chronic RAD in multivariate regression. From the area under ROC-curves were derived, that β2-MG level in serum and urine, and the activity of NAG in urine had the excellent and good power to classify patients with satisfactory function and chronic RAD.Conclusions. The increase of β2-MG in serum and urine may indicate glomerular and tubular dysfunction, respectively. An increase of urinary NAG indicates the ongoing damage of the tubules. The increase of IL-2 and IL-8 in the urine and IL-10 in serum may indicate the etiology of chronic RAD.


1980 ◽  
Vol 26 (8) ◽  
pp. 1193-1197 ◽  
Author(s):  
J Woo ◽  
M Floyd ◽  
M A Longley ◽  
D C Cannon

Abstract We describe a radioimmunoassay for beta 2-microglobulin (beta 2 mu) in serum and urine. We incubated aliquots of diluted samples at room temperature for 1 h with 125I-labeled beta 2 mu and a rabbit antiserum monospecific for human beta 2 mu, and separated the phases by the double-antibody technique. The logit-log transformed dose-response curve was linear in the range 2 to 64 ng, equivalent to 0.5 to 16 mg/L of serum and 0.5 to 320 mg/L of urine. Assay sensitivity was 2.4 ng of beta 2 mu. Validation studies included tests of precision, accuracy, antibody specificity, and parallelism of the dose-response curves for standard and unknown. In a study of 25 normal individuals, serum and urine beta 2 mu ranged from 1.1 to 2.3 mg/L and 40 to 360 micrograms/24 h; the clearance of beta 2 mu was 8 to 130 microL/min. In 21 renal allograft recipients tested one to five weeks after transplantation, serum and urine beta 2 mu ranged from 3.9 to 15.6 mg/L and 7.2 to 611 mg/24 h; beta 2 mu clearance was 0.60 to 33.3 mL/min. Values for both serum and urine correlated well with severity of allograft rejection.


1996 ◽  
Vol 58 (7) ◽  
pp. 617-622 ◽  
Author(s):  
Iwao KUNUGIYAMA ◽  
Nobuhiko ITO ◽  
Youko TAKAGAKI ◽  
Souichi HAYASHI ◽  
Kenji SONE ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document